MedPlus Health Services

MedPlus Health Services ROE

The Return on Equity (ROE) of MedPlus Health Services (MEDPLUS.NS) as of Nov 1, 2026 is 11.12 %. In the previous year, Return on Equity (ROE) was 8.64 % — a change of 28.75% (higher).

ROE

11.12 %

YoY

28.75%

Last updated:

In 2026, MedPlus Health Services's return on equity (ROE) was 11.12 %, a 28.75% increase from the 8.64 % ROE in the previous year.

The MedPlus Health Services ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
4.09 INR
Jan 1, 2020
0.41 INR
Jan 1, 2021
8.74 INR
Jan 1, 2022
6.76 INR
Jan 1, 2023
3.34 INR
Jan 1, 2024
4.15 INR
Jan 1, 2025
8.64 INR
Jan 1, 2026
11.12 INR
The MedPlus Health Services ROE history
YEARROEYoY
11.12 %+28.75%
8.64 %+108.14%
4.15 %+24.34%
3.34 %-50.61%
6.76 %-22.70%
8.74 %+2,016.30%
0.41 %-89.91%
4.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

MedPlus Health Services Stock analysis

What does MedPlus Health Services do? MedPlus Health Services Ltd operates pharmacies across multiple Indian states, serving customers through retail stores and an omni-channel platform. The company generates revenue from its Retail segment, which includes selling medicines, general items, fast-moving consumer goods, and beauty products, as well as from its Diagnostics segment offering laboratory testing services. The firm's subsidiaries, such as Optival Health Solutions Private Limited and MHS Pharmaceuticals Private Limited, support its operations in pharmaceutical manufacturing and distribution. With approximately 3,882 stores in 552 cities, MedPlus targets consumers seeking accessible healthcare solutions and diagnostic services. The company's primary buyers are individual consumers purchasing medicines, general merchandise, and beauty products through its retail outlets and online channels. Diagnostic services are utilized by patients requiring laboratory tests, often referred by healthcare providers. MedPlus leverages its extensive store network across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra to serve diverse customer segments in urban and semi-urban areas. Revenue streams include retail sales of pharmaceuticals, FMCG, and beauty products, wholesale trading of pharmaceuticals, and diagnostic testing services. The firm's omni-channel approach integrates physical stores with online platforms, enhancing customer reach and convenience. Subsidiaries like Kalyani Meditimes Private Limited contribute to the company's manufacturing and wholesale operations, supporting both segments. MedPlus Health Services is one of the most popular companies on Eulerpool.

ROE Details

Decoding MedPlus Health Services's Return on Equity (ROE)

MedPlus Health Services's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing MedPlus Health Services's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

MedPlus Health Services's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in MedPlus Health Services’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about MedPlus Health Services stock

Return on Equity (ROE) of MedPlus Health Services is 11.12 % in 2026.

Return on Equity (ROE) of MedPlus Health Services changed from 8.64 % to 11.12 %, representing a 28.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) MedPlus Health Services since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s MedPlus Health Services with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — MedPlus Health Services

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — MedPlus Health Services